We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.78%
2 Healthcare 3.27%
3 Industrials 2.02%
4 Financials 2.02%
5 Consumer Discretionary 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STR
10351
DELISTED
Sitio Royalties
STR
$62K ﹤0.01%
4,935
-763
-13% -$7.74K
USIO icon
10352
Usio Inc
USIO
$74.8M
$62K ﹤0.01%
+23,254
New +$41.3K
XHG
10353
XChange TEC
XHG
$155M
0
VIRX
10354
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$62K ﹤0.01%
8,917
-144,094
-94% -$752K
VCNX
10355
PUT
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$62K ﹤0.01%
143
-184
-56% -$77K
PEI
10356
CALL
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$62K ﹤0.01%
4,113
+2,506
+156% +$28.3K
CLIR icon
10357
CALL
ClearSign Technologies
CLIR
$30M
$61K ﹤0.01%
2,070
-2,030
-50% -$52.8K
AGIG
10358
Abundia Global Impact Group
AGIG
$40.2M
$61K ﹤0.01%
3,469
-39,490
-92% -$645K
ICL icon
10359
ICL Group
ICL
$7.19B
$61K ﹤0.01%
11,984
-14,346
-54% -$59.9K
KYN icon
10360
Kayne Anderson Energy Infrastructure Fund
KYN
$2.5B
$61K ﹤0.01%
+10,535
New +$56.5K
UTSI icon
10361
CALL
UTStarcom
UTSI
$23.4M
$61K ﹤0.01%
11,150
+4,375
+65% +$19.8K
REED
10362
DELISTED
Reeds, Inc. Common Stock
REED
$61K ﹤0.01%
+2,072
New +$81K
ARAY icon
10363
CALL
Accuray
ARAY
$33.7M
$60K ﹤0.01%
14,300
+3,900
+38% +$14.3K
BBVA icon
10364
CALL
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
$60K ﹤0.01%
12,100
+900
+8% +$3.46K
LXU icon
10365
CALL
LSB Industries
LXU
$744M
$60K ﹤0.01%
+23,140
New +$42K
WATT icon
10366
Energous
WATT
$83.4M
$60K ﹤0.01%
+56
New +$73.9K
KBNT
10367
DELISTED
Kubient, Inc. Common Stock
KBNT
$60K ﹤0.01%
10,668
-8,878
-45% -$36.7K
AHPI
10368
DELISTED
Allied Healthcare Products
AHPI
$60K ﹤0.01%
+12,353
New +$63.5K
AXU
10369
PUT
DELISTED
Alexco Resource Corp
AXU
$60K ﹤0.01%
+19,000
New +$49.9K
CHMA
10370
CALL
DELISTED
Chiasma, Inc. Common Stock
CHMA
$60K ﹤0.01%
+13,700
New +$57.1K
BBVA icon
10371
PUT
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
$59K ﹤0.01%
11,900
+800
+7% +$3.07K
QUIK icon
10372
PUT
QuickLogic
QUIK
$233M
$59K ﹤0.01%
15,500
-2,300
-13% -$7.16K
CHS
10373
CALL
DELISTED
Chicos FAS, Inc.
CHS
$59K ﹤0.01%
36,900
-6,200
-14% -$8.6K
CARM
10374
PUT
DELISTED
Carisma Therapeutics
CARM
$58K ﹤0.01%
2,160
+1,065
+97% +$27K
ABTS icon
10375
Abits Group
ABTS
$3.88M
$57K ﹤0.01%
+2,737
New +$51.6K

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.